Friday, November 19, 2010
Print Current Day:
|
|
SESSION 23 SCHEDULE | |
Friday
SESSION 23:
NEW STENT TECHNOLOGY AND IMPROVED TECHNIQUES (5-MINUTE TALKS)
Moderators:Enrico Ascher, MD / Timur P. Sarac, MD
|
|
x | |
6:40 AM - 6:45 AM | Component Bifurcated Iliac Graft For Preservation Of The Internal Iliac Artery During EVAR |
Presenters(s):William J. Quinones-Baldrich, MD | |
6:46 AM - 6:51 AM | Thin Film Nitinol Membrane Covered Stents Can Prevent Plaque Protrusion And Decrease Emboli |
Presenters(s):David Rigberg, MD | |
6:52 AM - 6:59 AM | A PTFE Mesh Covered Stent To Prevent Plaque Prolapse And Embolization |
Presenters(s):Sumaira Macdonald, MBChB (Comm), FRCP, FRCR, PhD | |
7:00 AM - 7:05 AM | Endovascular Treatment Of Critical Hand Ischemia Due To Below-The-Elbow Arterial Disease: Are Drug Eluting Balloons Helpful? |
Presenters(s):Roberto Ferraresi, MD | |
7:06 AM - 7:11 AM | A New All Purpose Guidewire Of Variable Size And Properties To Avoid Time Consuming Exchanges: How Does It Work? |
Presenters(s):Juan C. Parodi, MD / Claudio J. Schönholz, MD | |
7:12 AM - 7:17 AM | Results From The U.S. Aorfix Trial |
Presenters(s):Mark F. Fillinger, MD | |
7:18 AM - 7:23 AM | A Two Wire Technique And Special Catheter To Facilitate And Simplify CAS |
Presenters(s):Gioacchino Coppi, MD | |
7:24 AM - 7:28 AM | Panel Discussion |
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.) | |
Web-Based Presentation | 23.1 - New 3D Navigation Tools Using Merged CT And Fluoroscopic Images To Allow Wire And Catheter Navigation Without Contrast Injection |
Presenters(s):Jos C. van den Berg, MD, PhD | |
END OF SESSION 23 | |
SESSION 24 SCHEDULE | |
Friday
SESSION 24:
JUXTARENAL, PARARENAL AND THORACOABDOMINAL AORTIC ANEURYSMS (TAAAS), CHIMNEY OR SNORKEL GRAFTS AND OTHER TECHNIQUES TO REVASCULARIZE VISCERAL ARTERIES (5-MINUTE TALKS)
Moderators:Frank J. Veith, MD / W. Anthony Lee, MD
|
|
x | |
7:28 AM - 7:33 AM | Debate 12: Open Repair For Type IV TAAA Remains The Gold Standard For Most Good Risk Patients |
Presenters(s):Richard P. Cambria, MD | |
7:34 AM - 7:39 AM | Debate 12: Endovascular Repair With Branched Grafts Will Be Best For All Patients With Type IV TAAAs |
Presenters(s):Roy K. Greenberg, MD | |
7:40 AM - 7:45 AM | Results With An Off-The-Shelf Standardized Branched Endograft Device For TAAAs: When Can It Not Be Used? |
Presenters(s):Timothy A.M. Chuter, DM | |
7:46 AM - 7:51 AM | Do We Really Need Pre-Ordered And Off-The-Shelf Devices For Juxtarenal, Pararenal And TAAAs: How Are Surgeon-Modified Standard Endografts Improving |
Presenters(s):Gustavo S. Oderich, MD / Joseph J. Ricotta II, MD | |
7:52 AM - 7:57 AM | Debate 13: New Techniques To Optimize Results With Chimney Grafts To Revascularize Aortic Branches |
Presenters(s):Martin Malina, MD, PhD | |
7:58 AM - 8:03 AM | Debate 13: Limitations Of Chimney Grafts: They Are Not As Good As Some Say |
Presenters(s):Peter L. Harris, MD, FRCS | |
8:04 AM - 8:09 AM | Sandwich Technique For Improving Results With Chimney Grafts: Technique And Use For Hypogastric And Visceral Artery Branches |
Presenters(s):Armando C. Lobato, MD, PhD | |
8:10 AM - 8:15 AM | Multivessel “Terraced” Chimney Techniques For TAAAs: Will They Replace Branched Endografts |
Presenters(s):W. Anthony Lee, MD | |
8:16 AM - 8:21 AM | Treatment Of Juxta And Pararenal AAAs With Bilateral Parallel (Chimney) Grafts, Covered Palmaz Stents And Standard Aortic Grafts: When Can These Be Used And When Can’t They Be? |
Presenters(s):Ralf R. Kolvenbach, MD | |
8:22 AM - 8:27 AM | Periscope Chimney Technique To Help With Urgent Treatment Of TAAAs: Up And Down 4-Vessel Chimney Grafts |
Presenters(s):Mario Lachat, MD | |
8:28 AM - 8:33 AM | Technique For Retroperitoneal Approach To Abdominal (4-Vessel) Debranching For TAAAs: A Better Way |
Presenters(s):David H. Deaton, MD | |
8:34 AM - 8:39 AM | New Classification System For TAAAs In The Branched Graft Era |
Presenters(s):Marcelo Ferreira, MD | |
8:40 AM - 8:45 AM | Fenestrated Grafts: When Can They Be Used And When Should They Not Be? |
Presenters(s):Eric L.G. Verhoeven, MD, PhD | |
8:46 AM - 8:53 AM | Panel Discussion |
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.) | |
Web-Based Presentation | 24.1 - Deployment Problems With Branched And Fenestrated Endografts: Rescue Procedures From "Nightmares" |
Presenters(s):Marcelo Ferreira, MD | |
Web-Based Presentation | 24.2 - Fenestrated Grafts With Preloaded Wires: How Do They Help And Can Fenestrated And Branched Grafts Be Inserted With One Sided Access? |
Presenters(s):Krassi Ivancev, MD, PhD / David E. Hartley, FRANZCR (Hon) | |
Web-Based Presentation | 24.3 - A New Non-Sutured Telescoping Anastomotic Technique For Major Aortic Branch Revascularization With Minimal Dissection And Ischemia |
Presenters(s):Zoran Rancic, MD, PhD / Mario Lachat, MD / Dieter O. Mayer, MD | |
Web-Based Presentation | 24.4 - Lessons Learned And Technical Tips For Use Of Snorkel Or Chimney Grafts For Aortic Branch Revascularization |
Presenters(s):David J. Minion, MD | |
Web-Based Presentation | 24.5 - Tips And Tricks With Use Of The Snorkel/Chimney Technique To Facilitate Aortic Debranching And TEVAR |
Presenters(s):W. Charles Sternbergh III, MD | |
END OF SESSION 24 | |
SESSION 25 SCHEDULE | |
Friday
SESSION 25:
NEW DEVELOPMENTS IN THE TREATMENT OF LOWER EXTREMITY ISCHEMIA (5-MINUTE TALKS)
Moderators:Dennis F. Bandyk, MD / Kenneth Ouriel, MD, FACS, FACC
|
|
x | |
8:53 AM - 8:58 AM | What Percentage Of CLI Patients Will Ultimately Need An Open Procedure (Bypass Or Thrombectomy)? |
Presenters(s):Joseph L. Mills, MD | |
8:59 AM - 9:04 AM | When Endovascular Treatment And When Open Bypass For CLI: Do They Both Have A Role? |
Presenters(s):Sean P. Lyden, MD | |
9:05 AM - 9:10 AM | Debate 14: Endovascular Treatment For CLI Is More Cost Effective Than Distal Bypass |
Presenters(s):Luis A. Sanchez, MD | |
9:11 AM - 9:16 AM | Debate 14: For Patients With CLI Endovascular-Only Treatment Is Equally Costly To Open-Only Treatment Even Though Open-Only Was Used On Patients With Worse Disease |
Presenters(s):Nicholas J. Gargiulo III, MD | |
9:17 AM - 9:22 AM | With CLI And Multilevel Disease, When And How Often Will Aortoiliac Recanalization Be Adequate Treatment? |
Presenters(s):Carlo Setacci, MD | |
9:23 AM - 9:28 AM | Endovascular Recanalization Of The Occluded Aorta By A Foolproof Method Using A Reentry Device And Stents To Save Collaterals: Midterm Follow-Up Is Good |
Presenters(s):Ramon L. Varcoe, MD | |
9:29 AM - 9:34 AM | Is Buerger’s Disease Real Or Is It All Peripheral Arteriosclerosis And Should It All Be Treated As Such? |
Presenters(s):Kamphol Laohapensang, MD | |
9:35 AM - 9:40 AM | Use Of A Surrogate Walker And Plantar Bellows To Treat CLI Not Suitable For Endo Or Open Treatment: How Does It Work? |
Presenters(s):Magdiel Trinidad Vasquez, MD | |
9:41 AM - 9:46 AM | Panel Discussion |
Moderator(s): Enrico Ascher, MD / Dhiraj M. Shah, MD | |
9:46 AM - 9:51 AM | Pedal Bypass With Deep Vein Arterialization: A Therapeutic Option In Critical Ischemia With A Poor Distal Outflow Artery |
Presenters(s):Pramook Mutirangura, FRCS (Edinburgh) | |
9:52 AM - 9:57 AM | Debate 15: Progress In Bone Marrow Cell Treatment For CLI: It’s Not All Smoke And Mirrors And It May Save Limbs |
Presenters(s):John (Jeb) W. Hallett, MD | |
9:58 AM - 10:03 AM | Debate 15: Hyperbaric Oxygen And Good Wound Care Do Just As Well As Bone Marrow Cells In CLI |
Presenters(s):William A. Marston, MD | |
10:04 AM - 10:09 AM | BK Pop And Crural Bypasses With Heparin-Bonded PTFE (Propaten): How Well Do They Work? |
Presenters(s):Edward Y. Woo, MD | |
10:10 AM - 10:15 AM | RCT Comparing Propaten PTFE Stretch Grafts To Standard PTFE Stretch Grafts: A Multicenter Study Showing That Heparin Bonding Improves Patency |
Presenters(s):Jes S. Lindholt, MD | |
10:16 AM - 10:21 AM | 4-Year Results With Viabahn Endoluminal Stent Grafts Do As Well As Standard Prosthetic (PTFE And Dacron) Fem-Pop Bypasses For SFA Occlusive Disease In A RCT |
Presenters(s):Dennis R. Gable, MD, FACS | |
10:22 AM - 10:27 AM | High Platelet Count (> 400,000) Is A Predictor Of Early Failure Of Lower Extremity Bypasses: What Should Be Done About It? |
Presenters(s):Glenn M. LaMuraglia, MD | |
10:28 AM - 10:33 AM | Atherosclerotic (Degenerative) Femoral Artery Aneurysms: What Are The Criteria For Repair? |
Presenters(s):Peter F. Lawrence, MD | |
10:34 AM - 10:40 AM | Panel Discussion |
10:40 AM - 10:50 AM | Break / Visit Exhibits and Pavilions (2nd and 3rd Floors) |
Web-Based Presentation | 25.1 - What Is The Optimal Treatment For Mixed Arterial And Venous Ulcers? |
Presenters(s):Richard F. Neville, MD | |
END OF SESSION 25 | |
SESSION 26 SCHEDULE | |
Friday
SESSION 26:
ADVANCES IN MEDICAL TREATMENT AND TREATMENT OF MEDICAL PROBLEMS (5-MINUTE TALKS)
Moderators:Allan D. Callow, MD, PhD / Frank J. Veith, MD
|
|
x | |
10:50 AM - 10:55 AM | Debate 16: Beta Blockade Was Not Beneficial To AAA Repair And Leg Bypass Patients: A Study From The VSGNE Database |
Presenters(s):Jack L. Cronenwett, MD | |
10:56 AM - 11:01 AM | Debate 16: Beta Blockers Don’t Do Much But Statins Are Even Better Than We Realized In Vascular Surgery Patients: What Is The Proper Dosage? |
Presenters(s):Bruce A. Perler, MD, MBA | |
11:02 AM - 11:07 AM | Debate 16: Beta Blockers Are Beneficial In Vascular Surgery Patients And Need Not Increase Stroke Risk: They Just Have To Be Used Properly: What Is Proper Usage? |
Presenters(s):Don Poldermans, MD | |
11:08 AM - 11:13 AM | New Developments In Best Medical Treatment (BMRx): Are There Ways To Raise HDL Or Lower Triglycerides: When Are They Indicated And Do They Help Prevent Atherosclerotic Events? |
Presenters(s):Ron Waksman, MD | |
11:14 AM - 11:19 AM | Present Status And Future Possibilities With Drug Eluting Stents |
Presenters(s):Martin B. Leon, MD | |
11:20 AM - 11:25 AM | Aggressive Lipid Lowering Is Better Than Moderate Lipid Lowering In Stabilizing Carotid Plaques: What Dose Should We Give To Who, And How Does This Dose Change The Plaque? |
Presenters(s):Christos D. Liapis, MD | |
11:26 AM - 11:31 AM | New Opportunities And Best Management With Antiplatelet Therapy For Prevention Of Coronary Stent Thrombosis In Patients Undergoing Vascular Procedures |
Presenters(s):Ron Waksman, MD | |
11:32 AM - 11:37 AM | Should We Measure CRP Before Vascular Procedures: What Does A High CRP Mean And What Can Be Done About It? |
Presenters(s):Henrik Sillesen, MD, DMSc | |
11:38 AM - 11:43 AM | Cardiovascular Disease And Anti-Aging And Regenerative Medicines: A Revolution In Vascular Care |
Presenters(s):Sherif Sultan, MD, FRCS, EBQS-VASC | |
11:44 AM - 11:49 AM | How Low An LDL Level Should We Strive For In Our Vascular Disease Patients And Those Undergoing Procedures: Optimal Statin Dosing |
Presenters(s):Don Poldermans, MD | |
11:50 AM - 11:58 AM | Panel Discussion |
11:58 AM - 1:00 PM | Lunch Break – Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 26 | |
SESSION 27 SCHEDULE | |
Friday
SESSION 27:
SPECIAL SESSION ON RELATIONSHIPS BETWEEN INDUSTRY, PHYSICIANS, CME AND ADVAMED (7-MINUTE TALKS)
Moderators:Richard A. Baum, MD / Keith D. Calligaro, MD
|
|
x | |
12:03 PM - 12:10 PM | Is The Medical Inquisition Here To Stay: State And Federal Governments, ADVAMED And Some Universities Are Imposing Unfair Restrictions On Physicians And Industry Which Will Prevent Physician Education And Harm Patients: This Witch Hunt Must Stop |
Presenters(s):Zvonimir Krajcer, MD, FACC | |
12:11 PM - 12:18 PM | Rules About CME Are Unreasonable And Part Of A Witch Hunt That Harms CME And Ultimately Will Harm Patients |
Presenters(s):Lowell S. Kabnick, MD, FACS, FACPh | |
12:19 PM - 12:26 PM | What Will Be Lost By Conflict Of Interest Mandates To Separate Practicing Physicians And Surgeons From Industry? |
Presenters(s):Russell H. Samson, MD, RVT, FACS | |
12:27 PM - 12:34 PM | What Will Happen To Large CME Meetings And What Can We Do About It? |
Presenters(s):Barry T. Katzen, MD | |
12:35 PM - 12:42 PM | Redesigning The Relationship Between Physicians And Industry So That Everyone Wins |
Presenters(s):Richard A. Baum, MD | |
12:43 PM - 12:58 PM | Questions And Discussion |
END OF SESSION 27 | |
SESSION 28 SCHEDULE | |
Friday
SESSION 28:
MORE ON THORACIC AORTIC ANEURYSMS (TAAS) AND AAAS AND THEIR TREATMENT AND PREVENTION (5-MINUTE TALKS)
Moderators:Wesley S. Moore, MD / Matt M. Thompson, MD
|
|
x | |
1:00 PM - 1:05 PM | Improved Grafts For TEVAR: The VALIANT And CAPTIVA Systems: Early Results |
Presenters(s):Ronald M. Fairman, MD | |
1:06 PM - 1:11 PM | New Findings From The INSTEAD Trial: Remodeling With And Without Endograft Treatment: What Is The Significance Of The Differing Results? |
Presenters(s):Christoph A. Nienaber, MD, PhD | |
1:12 PM - 1:17 PM | CT Follow-up After EVAR Is Bad For The Kidneys |
Presenters(s):Jan S. Brunkwall, MD, PhD | |
1:18 PM - 1:23 PM | Preoperative Relative AAA Thrombus Burden Predicts Endoleak And Sac Enlargement After EVAR |
Presenters(s):Thomas S. Maldonado, MD | |
1:24 PM - 1:29 PM | Bioenhanced Devices With Local Drug Delivery Have A Role In AAA Treatment |
Presenters(s):Ronald L. Dalman, MD | |
1:30 PM - 1:35 PM | New Technology For Extravascular Or Intravascular Stabilization Of AAAs: The VATRIX System To Influence The AAA Wall |
Presenters(s):Christopher J. Kwolek, MD | |
1:36 PM - 1:41 PM | Debate 17: We Must Have Level I Evidence That EVAR Is Better Than Open Repair For Ruptured AAAs |
Presenters(s):Nicholas J.W. Cheshire, MD | |
1:42 PM - 1:47 PM | Debate 17: EVAR For Ruptured AAAs Is Better: Open Treatment If The Patient Has Favorable Anatomy Is Akin To Murder |
Presenters(s):Sherif Sultan, MD, FRCS, EBQS-VASC | |
1:48 PM - 1:53 PM | How Best To Treat Patients With An AAA And Iliac Occlusive Disease: Tips And Tricks |
Presenters(s):Andrew Holden, MBChB | |
1:54 PM - 1:59 PM | Duplex Ultrasonography Done Early After EVAR Can Predict Which Type II Endoleaks Are Going To Persist And Lead To AAA Sac Enlargement |
Presenters(s):Keith D. Calligaro, MD | |
2:00 PM - 2:05 PM | How Often Does Embolization Of Type II Endoleaks Prevent Sac Expansion: What Can Be Done When It Fails? |
Presenters(s):Timur P. Sarac, MD | |
2:06 PM - 2:12 PM | Panel Discussion |
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.) | |
Web-Based Presentation | 28.1 - 1-Year Trial Results With The VALIANT Stent-Graft For Treatment Of Complicated Type B Aortic Dissections |
Presenters(s):Matt M. Thompson, MD | |
END OF SESSION 28 | |
SESSION 29 SCHEDULE | |
Friday
SESSION 29:
PROGRESS IN VASCULAR IMAGING FOR INTERVENTIONALISTS (5-MINUTE TALKS)
Moderators:Mark A. Adelman, MD / Nicholas J.W. Cheshire, MD
|
|
x | |
2:12 PM - 2:17 PM | Aneurysm Neck Dynamics As Seen By 4D MRA: How Will It Influence The Choice Of Endograft And EVAR Outcomes? |
Presenters(s):Frans L. Moll, MD, PhD | |
2:18 PM - 2:23 PM | CTA/PET Scanning And Its Value In Diagnosis And Treatment Of Vascular Disease |
Presenters(s):Allan W. Reid, FRCR | |
2:24 PM - 2:29 PM | Dynamic CT Fusion With Prior CTA: How Will It Improve Interventions And Decrease Dye Loads And X-ray Exposure: How Does It Work? |
Presenters(s):Matthew J. Eagleton, MD | |
2:30 PM - 2:35 PM | Value Of 3D Rotational CTA To Facilitate Fenestrated/Branched Endograft Placement |
Presenters(s):Krassi Ivancev, MD, PhD | |
2:36 PM - 2:41 PM | Dual Energy CT In Vascular Imaging: Advantages And Limitations |
Presenters(s):Jos C. van den Berg, MD, PhD | |
2:42 PM - 2:47 PM | Can CTA Evaluate The Circle Of Willis: How Can This Help In CEA And CAS? |
Presenters(s):Michael H. Wholey, MD, MBA | |
2:48 PM - 2:53 PM | Improvements In TeraRecon 3D Imaging For EVAR And TEVAR: It Is Now Easier For Surgeons To Use |
Presenters(s):Mark A. Farber, MD | |
2:54 PM - 2:59 PM | Progress In The Value Of IVUS And Virtual Histology In Various Vascular Beds |
Presenters(s):Donald B. Reid, MD | |
3:00 PM - 3:05 PM | Pre And Post Procedural Imaging For Lower Extremity Arteriosclerosis: Which Is Best And How To Make Them Better With 3D Post Processing |
Presenters(s):Barry Stein, MD, FSIR, FACR | |
3:06 PM - 3:11 PM | Panel Discussion and Break – Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 29 | |
SESSION 30 SCHEDULE | |
Friday
SESSION 30:
PROGRESS IN VENOUS DISEASE AND ITS TREATMENT (5-MINUTE TALKS) – PART I
Moderators:Bo G. Eklof, MD, PhD / Ramesh K. Tripathi, MD, FRCS, FRACS
|
|
x | |
3:19 PM - 3:24 PM | RCT Comparison Of IVC Filters: Greenfield vs. TrapEase: Which Causes More Caval Thrombosis? |
Presenters(s):Anil P. Hingorani, MD | |
3:25 PM - 3:30 PM | Debate 18: The Greater Saphenous Vein Should Be Preserved When Treating Most Varicose Veins |
Presenters(s):Paul Pittaluga, MD | |
3:31 PM - 3:36 PM | Debate 18: The Greater Saphenous Vein Should Almost Never Be Preserved When Treating Varicose Veins |
Presenters(s):Peter Gloviczki, MD | |
3:37 PM - 3:42 PM | Complications Of Radiofrequency And Laser Endovenous Ablation |
Presenters(s):Mark H. Meissner, MD | |
3:43 PM - 3:48 PM | Reduction Of Venous Ulcers By 50%: Is That Feasible In The U.S. In 10 Years? Report From American Venous Forum’s Expert Meeting In Hawaii November 2009 |
Presenters(s):Bo G. Eklof, MD, PhD | |
3:49 PM - 3:54 PM | Debate 19: Deep Venous Thrombectomy With AVF: It Still Has A Role In The Endovascular Era |
Presenters(s):Wilhelm Sandmann, MD | |
3:55 PM - 4:00 PM | Debate 19: Catheter Directed Thrombolysis Is The Best Treatment For Most Patients With Ileofemoral DVT: It Decreases Postphlebitic Syndrome And Recurrent DVT |
Presenters(s):Anthony J. Comerota, MD, FACS, FACC | |
4:01 PM - 4:06 PM | Debate 19: Anticoagulation Is Best For Most DVT Patients: The Only Reason For The Endovascular Treatment Of DVT Is To Provide Business For Interventionalists |
Presenters(s):Erich Minar, MD | |
4:07 PM - 4:12 PM | Tips And Tricks For Performing Lytic Treatment For DVT: Technique Matters |
Presenters(s):Thomas O. McNamara, MD | |
4:13 PM - 4:18 PM | Panel Discussion |
Moderator(s): Mark H. Meissner, MD / Joann Lohr, MD | |
4:19 PM - 4:24 PM | Treatment Of Pulmonary Emboli With Catheter Directed Ultrasound (EKOS) Thrombolysis: A Better Way |
Presenters(s):Peter H. Lin, MD | |
4:25 PM - 4:30 PM | Safety, Value And Advantages Of A New Ultrasound Technique (EKOS) For Thrombolysis In DVT |
Presenters(s):Frank R. Arko, MD | |
4:31 PM - 4:36 PM | Inflammatory Biomarkers That Allow A Blood Test Diagnosis Of DVT |
Presenters(s):Thomas W. Wakefield, MD | |
4:37 PM - 4:42 PM | Hyperbaric Oxygen Therapy Is More Effective Clinically And In Terms Of Cost Than Compression Treatment For Refractory Venous Ulcers |
Presenters(s):Niamh Hynes, MD | |
4:43 PM - 4:48 PM | Panel Discussion |
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.) | |
Web-Based Presentation | 30.1 - Further Experience With The ROTAREX Device In The Treatment Of Massive Pulmonary Emboli |
Presenters(s):Marcelo Ferreira, MD | |
Web-Based Presentation | 30.2 - Discovery Of Venous Valves: Myth Or Reality? |
Presenters(s):J. Leonel Villavicencio, MD | |
END OF SESSION 30 | |
SESSION 31 SCHEDULE | |
Friday
SESSION 31:
PROGRESS IN VENOUS DISEASE (5-MINUTE TALKS) – PART II
Moderators:J. Leonel Villavicencio, MD / Seshadri Raju, MD
|
|
x | |
4:48 PM - 4:53 PM | Advances In Venous Disease Research In 2010 |
Presenters(s):Mark H. Meissner, MD | |
4:54 PM - 4:59 PM | Complications After IVC Retrievable Filters Can Damage Adjacent Structures: How To Prevent Such Damage |
Presenters(s):Kim J. Hodgson, MD | |
5:00 PM - 5:05 PM | The NOVATE Bioconvertible IVC Filter: The Next Generation Device Where The Filter Converts To A Stent |
Presenters(s):David Rosenthal, MD | |
5:06 PM - 5:11 PM | Debate 20: We Need Stricter Criteria For Use Of Caval Interruption Devices |
Presenters(s):David L. Gillespie, MD | |
5:12 PM - 5:17 PM | Debate 20: We Do Not Need Stricter Criteria For Use Of Caval Interruption Devices |
Presenters(s):Michael C. Dalsing, MD | |
5:18 PM - 5:23 PM | Indications And Technique For Treating Popliteal Venous Aneurysms: Why Are They Dangerous? |
Presenters(s):Fredric Jarrett, MD | |
5:24 PM - 5:29 PM | Debate 21: Stents Are Usually Required In The Endovascular Treatment Of Chronic Venous Disease |
Presenters(s):Seshadri Raju, MD | |
5:30 PM - 5:35 PM | Debate 21: Stents Are Best Avoided In The Endovascular Treatment Of Chronic Venous Disease |
Presenters(s):Gregory L. Moneta, MD | |
5:36 PM - 5:41 PM | How To Deal With The Large Marginal Lateral Vein In Klippel Trenaunay Syndrome Patients: Excision, Laser, Foam Or Retreat? |
Presenters(s):J. Leonel Villavicencio, MD | |
5:42 PM - 5:47 PM | Best Practice Guidelines For Managing Venous Ulcers: What Is Best And What Is Really Being Done In The US And Europe? |
Presenters(s):Thomas F. O'Donnell, Jr., MD | |
5:48 PM - 5:53 PM | Conservative Treatment With Compression And Antiplatelet Agents Is As Effective As Anticoagulation With Isolated Gastrocnemius Or Soleal DVT |
Presenters(s):Clifford M. Sales, MD, MBA | |
5:54 PM - 5:59 PM | Aggressive Treatment Of Chronic DVT With Thrombolysis And Mechanical Clot Removal: When Is It Indicated And Does It Work? |
Presenters(s):Mark J. Garcia, MD | |
6:00 PM - 6:05 PM | Panel Discussion |
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.) | |
Web-Based Presentation | 31.1 - Endovascular And Combined Endovascular-Surgical Treatment For DVT |
Presenters(s):Jos C. van den Berg, MD, PhD | |
Web-Based Presentation | 31.2 - Why Is Screening For Venous Disease Important: 5-Year Report From The National Venous Screening Program Of The AVF |
Presenters(s):Marc A. Passman, MD | |
Web-Based Presentation | 31.3 - The CHIVA Procedure For Leaving The Greater Saphenous Vein Intact When Treating Varicose Veins: Why Does It Work? |
Presenters(s):Mohan Adiseshiah, FRCS | |
Web-Based Presentation | 31.4 - Endovascular Treatment Of Varicocele And Pelvic Congestion Syndrome: Technique And Results |
Presenters(s):Peter H. Lin, MD | |
END OF SESSION 31 |